Potential clinical implications of mir-1 and mir-21 in heart disease and cardioprotection

Branislav Kura, Barbora Kalocayova, Yvan Devaux, Monika Bartekova*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

65 Citations (Scopus)


The interest in non-coding RNAs, which started more than a decade ago, has still not weakened. A wealth of experimental and clinical studies has suggested the potential of non-coding RNAs, especially the short-sized microRNAs (miRs), to be used as the new generation of therapeutic targets and biomarkers of cardiovascular disease, an ever-growing public health issue in the modern world. Among the hundreds of miRs characterized so far, microRNA-1 (miR-1) and microRNA-21 (miR-21) have received some attention and have been associated with cardiac injury and cardioprotection. In this review article, we summarize the current knowledge of the function of these two miRs in the heart, their association with cardiac injury, and their potential cardioprotective roles and biomarker value. While this field has already been extensively studied, much remains to be done before research findings can be translated into clinical application for patient’s benefit.

Original languageEnglish
Article number700
JournalInternational Journal of Molecular Sciences
Issue number3
Publication statusPublished - 1 Feb 2020


  • Biomarkers
  • Cardioprotection
  • Cardiovascular diseases
  • MicroRNA-1 (miR-1)
  • MicroRNA-21 (miR-21)


Dive into the research topics of 'Potential clinical implications of mir-1 and mir-21 in heart disease and cardioprotection'. Together they form a unique fingerprint.

Cite this